Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 1
Phase 1a/1b Study of CT-95 in Advanced Cancers Associated With Mesothelin Expression
This is a Phase 1a/1b, first-in-human (FIH), open-label, multi-center dose escalation and expansion study of the safety, pharmacokinetics (PK), pharmacodynamic…
Mesothelin-Expressing TumorsEpithelial Ovarian CancerMalignant Pleural Mesothelioma, Advanced+8 more
Estimated
~$10 – $8,750
Context Therapeutics Inc.NCT06756035
Phase 1
A Phase 1, Single-Arm, Open-Label, Dose-Escalation, Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of CS231295 in Patients With Advanced Solid Malignant Tumors
This is a Phase I, single-arm, open-label, dose-escalation, multicenter clinical study of CS231295 in patients with advanced solid malignant tumors. Eligible …
Advance Solid TumorsAdvanced Malignant Solid Tumors
Estimated
~$10 – $8,750
ThalassaX Therapeutics United States LtdNCT07612488